Cordyceps 10:1 vs 1:1

Plants and fungi are much more complex than just X% of a single active. We list the cordycepin, because that is what everyone assumed was the main active. However, we also knew our 10:1 felt stronger to most people, so we have been trying to figure out why for a while. We've been doing a lot of research, and a lot of R&D in our lab. We think we have finally solved it, but we want to validate that data before we say 100% for sure. Once we validate it, things should make a lot more sense on the stimulation side of things. Everyone has just been looking at the incorrect active compound forever, and nobody has thought to question it.

I can open up a whole other can of worms on beta-glucans. We have done a lot of lab work there, too. There are different types of beta-glucans, and we think there is a limitation of the current Megazyme methodology that needs to be accounted for. To put it simply, the chitin in the cell walls of a mushroom will show up as a beta-glucan in the Megazyme method. This means that our 1:1 powders that don't discard any mushroom material will show higher beta-glucan numbers than the extracts that discard the material. This is because chitin is not soluble in water or ethanol, so it gets taken out of extracts. This means that the more concentrated extracts appear less concentrated. However, that's just the loss of the insoluble chitin. They actually have more of the beneficial beta-glucans we want, but the current Megazyme methods can't tell the difference. We have been working on a way to solve that, but the chemistry is actually more difficult than it sounds. We will solve it, but it is going to take a lot of lab work. The medicinal mushroom side of this industry is in its infancy, to be honest. So much more science needs to be done to bring it up to the same level as botanicals. I literally had to build our own analytical lab, and hire PhD chemists, to start to solve some of these things. It's been years of work.

In simple terms, the 10:1 will be more potent. That's not because of cordycepin, but another compound related to it. Once we validate all our data, we will start reporting that number as well, and also publish our findings. Once we solve the beta-glucan issue, we will also publish our findings on that, too.